In an experimental trial, a personalized mRNA vaccine was tested in 14 individuals with an aggressive form of breast cancer. It trained immune cells to target cancer-specific mutant proteins, inducing ...
Department of Chemistry and Biochemistry, University of South Carolina, Columbia, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results